Pancreatic Cancer Research

ResearcherComprehensive Cancer Center ViennaActive in the last 2 years

Elisabeth S. Gruber

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8646-1865; OpenAlex author ID A5003717847. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2019: 1 paper · 2020: 4 papers · 2021: none · 2022: 1 paper · 2023: none · 2024: 1 paper

Papers 7

  1. Prognostic significance of mean corpuscular volume in patients with pancreatic ductal adenocarcinoma and multimodal treatment. Co-author DOI 10.1016/j.jviscsurg.2023.06.004↗
  2. A GATA6-centred gene regulatory network involving HNFs and ΔNp63 controls plasticity and immune escape in pancreatic cancer. Co-author DOI 10.1136/gutjnl-2020-321397↗
  3. Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection. First author DOI 10.1007/s11605-019-04187-z↗
  4. The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Co-author DOI 10.1245/s10434-019-08161-6↗
  5. Reply to Comments by Sun et al. on "The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection… Co-author DOI 10.1245/s10434-020-08373-1↗
  6. Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection. Co-author DOI 10.1245/s10434-020-09010-7↗
  7. Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma. Co-author DOI 10.1371/journal.pone.0215915↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Martin Schindl · 7 shared papers, 2019–2024 · strength 1.01
  2. Klaus Sahora · 5 shared papers, 2019–2024 · strength 0.70
  3. Gerd Jomrich · 5 shared papers, 2019–2024 · strength 0.70
  4. Michael Gnant · 4 shared papers, 2019–2020 · strength 0.51
  5. Gerald W. Prager · 1 shared paper, 2024 · strength 0.19
  6. Bernhard Kloesch · 1 shared paper, 2022 · strength 0.12
  7. Sebastian Mueller · 1 shared paper, 2022 · strength 0.12
  8. Roland Rad · 1 shared paper, 2022 · strength 0.12
  9. Raul A. Urrutia · 1 shared paper, 2022 · strength 0.12
  10. Gwen Alyce Lomberk · 1 shared paper, 2022 · strength 0.12
  11. Paola Martinelli · 1 shared paper, 2022 · strength 0.12
  12. Francisco X. Real · 1 shared paper, 2022 · strength 0.12
  13. Dieter Saur · 1 shared paper, 2022 · strength 0.12

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.